Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey

Rabia Hussain, Tayyaba Akram, Mohamed Azmi Hassali, Jaya Muneswarao, Anees ur Rehman, Furqan Hashmi, Zaheer Ud Din Babar

Research output: Contribution to journalArticlepeer-review

Abstract

The timely reporting of adverse drug reactions (ADRs) could improve pharmacovigilance (PV) in a healthcare system. However, in almost all healthcare systems barriers exist that lead to the underreporting of ADRs. The objective of this study was to identify the barriers and facilitators regarding PV activities from the point of view of healthcare professionals (HCPs) in Lahore, Pakistan. A cross-sectional questionnaire-based survey was conducted between September 2018 to January 2019. The data was collected through convenience sampling of physicians, pharmacists, and nurses at tertiary care public hospitals in Lahore. A total of 384 questionnaires were distributed, and 346 HCPs responded to the survey. Over 62% percent of physicians and 54.8% of nurses agreed that they did not know how to report an ADR in their workplace. About 43.2% of pharmacists and 40.1% of nurses disagreed that they were not aware of the need for ADR reporting. Furthermore, 41.6% of nurses identified a lack of financial reimbursement and 51.8% highlighted a lack of support from a colleague as a reason that could lead to the underreporting of ADR. The majority of participants, including 69.6% physicians, 48.6% pharmacists, and 55.3% nurses identified the lack of knowledge about the existence of a national PV centre. Extra time for ADR reporting, incentives, continuous medical education, reminders, and availability of an online ADR reporting system was classed as the facilitators and were agreed upon by the majority of HCPs.

Original languageEnglish
Article numbere0271587
Number of pages15
JournalPLoS One
Volume17
Issue number7
DOIs
Publication statusPublished - 29 Jul 2022

Fingerprint

Dive into the research topics of 'Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey'. Together they form a unique fingerprint.

Cite this